ArticleAlimentary pharmacology & therapeutics2026

Comparative Real-World Effectiveness of Anti-TNF, Ustekinumab and Vedolizumab in Crohn's Disease Over 24 Months: A Pooled Analysis From the Prospective UMBRELLA-IBD Registry in Germany.

Arne Bokemeyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.